Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Rapilif-M 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Mirabegron (50mg) + Silodosin (8mg)

Overview Rapilif-M 50 Tablet ER

Rapilif-M 50 ER tablets are a combined medication employed to manage benign prostatic hyperplasia (BPH). This treatment alleviates symptoms such as urinary hesitancy, but doesn't reduce prostate volume. Always adhere to your physician's prescribed dosage and regimen. Consumption can be with or without food, maintaining consistent daily timing. Swallow the tablet whole; avoid crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, necessitating completion of the prescribed course for optimal results. Potential side effects include dizziness, diarrhea, retrograde ejaculation, orthostatic hypotension, headache, nasal congestion, and nasopharyngitis. Persistent or bothersome side effects warrant immediate medical attention. Simple lifestyle adjustments can aid symptom management. Urinate promptly upon feeling the urge, avoiding straining. Limit evening and pre-sleep consumption of caffeinated or alcoholic beverages. Prior to treatment, disclose all current medications and pre-existing conditions. Inform your ophthalmologist about Rapilif-M 50 ER use before cataract or glaucoma surgery. Individuals with hepatic or renal impairment require careful monitoring and regular checkups under their doctor's guidance.

Uses of Rapilif-M 50 Tablet ER

Noncancerous prostate gland enlargement

Major Benefits of Rapilif-M 50 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rapilif-M 50 Tablet ER whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.

Common Side effects of Rapilif-M 50 Tablet ER:

  • Retrograde ejaculation
  • Dizziness
  • Diarrhea
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Headache
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Nasal congestion (stuffy nose)

How to use Rapilif-M 50 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rapilif-M 50 Tablet ER whole; avoid chewing, crushing, or fracturing it. This extended-release tablet can be consumed with or without food, though consistent timing is recommended.

How Rapilif-M 50 Tablet ER works:

Rapilif-M 50 Extended-Release tablets contain mirabegron and silodosin. Mirabegron eases bladder muscle contractions, reducing urinary urgency, frequency, and incontinence. Silodosin similarly relaxes muscles in both the bladder and prostate gland.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Rapilif-M 50 Tablet ER lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Rapilif-M 50 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Rapilif-M 50 Tablet ER while breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Rapilif-M 50 Tablet ER's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Rapilif-M 50 Tablet ER use in individuals with impaired renal function is scarce. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Rapilif-M 50 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Rapilif-M 50 Tablet ER :

Should you forget a Rapilif-M 50 Tablet ER dose, administer it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Rapilif-M 50 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Urology

FAQs on Rapilif-M 50 Tablet ER

This medication can lower your blood pressure, especially with the first dose. Therefore, avoid driving, operating machinery, or performing critical tasks for the first few days of treatment. Consult your doctor before starting this medication.
Always consult your doctor before starting Rapilif-M 50 Tablet ER. This medication may cause low blood pressure and fainting, a risk heightened by concurrent sildenafil use. Some individuals are particularly susceptible to this potentially dangerous drop in blood pressure and increased risk of fainting.
Continue taking Rapilif-M 50 Tablet ER even if your symptoms improve. This medication doesn't cure benign prostatic hyperplasia, but manages symptoms such as painful, frequent urination and urgency. Discontinuing treatment could cause symptoms to return.
This medication can lower your blood pressure, especially with the first dose. Therefore, avoid driving, operating machinery, or performing critical tasks initially. Consult your doctor before starting this medicine.
Always consult your doctor before starting Rapilif-M 50 Tablet ER. This medication may cause low blood pressure and fainting, a risk heightened by concurrent sildenafil use. This combination may significantly increase the likelihood of fainting in susceptible individuals, posing a safety concern.
Continue taking Rapilif-M 50 Tablet ER even if your symptoms improve. This medication doesn't cure benign prostatic hyperplasia, but manages symptoms such as painful and frequent urination, and urinary urgency. Discontinuing treatment may cause your symptoms to return.
Rapilif-M 50 Tablet ER
468
MRP 570
17% off